Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/11/2017
SIETES contiene 92130 citas

 
 
 1 a 20 de 35 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Tricco AC, Thomas SM, Veroniki AA, Hamid JS, Cogo E, Strifler L, Khan PA, Robson R, Sibley KM, MacDonald H, Riva JJ, Thavorn K, Wilson C, Holroyd-Leduc J, Kerr GD, Feldman F, Majumdar SR, Jaglal SB, Hui W, Straus SE. Comparisons of interventions for preventing falls in older adults. A systematic review and meta-analysis. JAMA 2017;318:1687-99. [Ref.ID 102139]
2. Cita con resumen
3. Cita con resumen
Zaccara G, Giovannelli F, Giorgi FS, Franco V, Gasparini S, Benedetto U. Tolerability of new antiepileptic drugs: a network meta-analysis. Eur J Clin Pharmacol 2017;73:811-7. [Ref.ID 101994]
4.Tiene citas relacionadas Cita con resumen
da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, Trelle S. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet 2017;390:8 de julio. [Ref.ID 101669]
5. Cita con resumen
Hutton B, Catalá-López F, Moher D. La extensión de la declaración PRISMA para revisiones sistemáticas que incorporan metaanálisis en red: PRISMA-NMA. Med Clin (Barc) 2016;147:262-6. [Ref.ID 100724]
6.Tiene citas relacionadas Cita con resumen
Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet 2016;388:881-90. [Ref.ID 100612]
7. Cita con resumen
Whittle J. Blood pressure variability and cardiovascular risk. BMJ 2016;354:i4190. [Ref.ID 100604]
8. Cita con resumen
Stevens SL, Wood S, Koshiaris C, Law K, Glasziou P, Stevens RJ, McManus RJ. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ 2016;354:i4098. [Ref.ID 100603]
10.Tiene citas relacionadas Cita con resumen
da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, Trelle S. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet 2016;387:2093-105. [Ref.ID 100313]
11.Tiene citas relacionadas Cita con resumen
Moore N, Salvo F, Duong M, Gulmez SE. Does paracetamol still have a future in osteoarthritis?. Lancet 2016;387:2065-6. [Ref.ID 100312]
12. Cita con resumen
Rouse B, Cipriani A, Shi Q, Coleman AL, Dickersin K, Li T. Network meta-analysis for clinical practice guidelines: a case study, on first-line medical therapies for primary open-angle glaucoma. Ann Intern Med 2016;164:674-82. [Ref.ID 100297]
13. Cita con resumen
Catalá-López F, Macías Saint-Gerons D, González-Bermejo D, Rosano GM, Davis BR, Ridao M, Zaragoza A, Montero-Corominas D, Tobías A, de la Fuente-Honrubia C, Tabarés-Seisdedos R, Hutton B. Cardiovascular and renal outcomes of renin–angiotensin system blockade in adult patients with diabetes mellitus: a systematic review with network meta-analyses. PLOS Medicine 2016:8 de marzo. [Ref.ID 100213]
14. Cita con resumen
Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387:957-67. [Ref.ID 100151]
15. Cita con resumen
Bangalore S, Fakheri R, Toklu B, Ogedegbe G, Weintraub H, Messerli FH. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients without heart failure? Insights from 254,301 patients from randomized trials. Mayo Clin Proc 2016;91:51-60. [Ref.ID 99976]
16. Cita con resumen
Palmerini T, Benedetto U, Biondi-Zoccai G, Della Riva D, Bacchi-Reggiani L, Smits PC, Vlachonjannis GJ, Jensen LO, Christiansen EH, Berencsi K, Valgimigli M, Orlandi C, Petrou M, Rapezzi C, Stone GW. Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol 2015;65:2496-507. [Ref.ID 99444]
17.Tiene citas relacionadas Cita con resumen
Li B-Z, Threapleton DE, Wang JY, Xu J-M, Yuan J-Q, Zhang C, Li P, Ye Q-L, Guo B, Mao C, Ye DQ. Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis. BMJ 2015;351:h4052. [Ref.ID 99413]
18.Tiene citas relacionadas Cita con resumen
Braden B. The best and worst treatments for Helicobacter pylori. BMJ 2015;351:h4146. [Ref.ID 99411]
19.Tiene citas relacionadas Cita con resumen
Siontis GCM, Stefanini GG, Mavridis D, Siontis KC, Alfonso F, Pérez-Vizcayno MJ, Byrne RA, Kastrati A, Meier B, Salanti G, Jüni P, Windecker S. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis. Lancet 2015;386:655-64. [Ref.ID 99406]
20.Tiene citas relacionadas Cita con resumen
Higgins JPT, Welton NJ. Network meta-analysis: a norm for comparative effectiveness?. Lancet 2015;386:628-30. [Ref.ID 99405]
Seleccionar todas
 
 1 a 20 de 35 siguiente >>